BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22663303)

  • 1. Delivery to mitochondria: a narrower approach for broader therapeutics.
    Malhi SS; Murthy RS
    Expert Opin Drug Deliv; 2012 Aug; 9(8):909-35. PubMed ID: 22663303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
    Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
    Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting drugs to mitochondria.
    Heller A; Brockhoff G; Goepferich A
    Eur J Pharm Biopharm; 2012 Sep; 82(1):1-18. PubMed ID: 22687572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting mitochondria: strategies, innovations and challenges: The future of medicine will come through mitochondria.
    Edeas M; Weissig V
    Mitochondrion; 2013 Sep; 13(5):389-90. PubMed ID: 23562877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted drug delivery to mammalian mitochondria in living cells.
    Weissig V
    Expert Opin Drug Deliv; 2005 Jan; 2(1):89-102. PubMed ID: 16296737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Targeting mitochondria: innovation from mitochondrial drug delivery system (DDS) to mitochondrial medicine].
    Yamada Y; Harashima H
    Yakugaku Zasshi; 2012; 132(10):1111-8. PubMed ID: 23037696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases.
    Yamada Y; Harashima H
    Adv Drug Deliv Rev; 2008; 60(13-14):1439-62. PubMed ID: 18655816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial therapeutic interventions in Alzheimer's disease.
    Van Giau V; An SSA; Hulme JP
    J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial medicine: pharmacological targeting of mitochondria in disease.
    Armstrong JS
    Br J Pharmacol; 2007 Aug; 151(8):1154-65. PubMed ID: 17519949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mitochondrial drug delivery for cancer therapy].
    Han M; Li C; Guo WW; Liu HN; Liang WQ; Gao JQ
    Yao Xue Xue Bao; 2016 Feb; 51(2):257-63. PubMed ID: 29856579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology inspired tools for mitochondrial dysfunction related diseases.
    Wen R; Banik B; Pathak RK; Kumar A; Kolishetti N; Dhar S
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):52-69. PubMed ID: 26776231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osthole attenuates spinal cord ischemia-reperfusion injury through mitochondrial biogenesis-independent inhibition of mitochondrial dysfunction in rats.
    Zhou YF; Li L; Feng F; Yuan H; Gao DK; Fu LA; Fei Z
    J Surg Res; 2013 Dec; 185(2):805-14. PubMed ID: 23899510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-Targeting Peptoids.
    Nam HY; Hong JA; Choi J; Shin S; Cho SK; Seo J; Lee J
    Bioconjug Chem; 2018 May; 29(5):1669-1676. PubMed ID: 29578690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting antioxidants to mitochondria: a new therapeutic direction.
    Sheu SS; Nauduri D; Anders MW
    Biochim Biophys Acta; 2006 Feb; 1762(2):256-65. PubMed ID: 16352423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical targeted hepatocyte mitochondrial multifunctional chitosan nanoparticles for anticancer drug delivery.
    Chen Z; Zhang L; Song Y; He J; Wu L; Zhao C; Xiao Y; Li W; Cai B; Cheng H; Li W
    Biomaterials; 2015 Jun; 52():240-50. PubMed ID: 25818430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-Mediated Delivery of Chemical Probes and Therapeutics to Mitochondria.
    Jean SR; Ahmed M; Lei EK; Wisnovsky SP; Kelley SO
    Acc Chem Res; 2016 Sep; 49(9):1893-902. PubMed ID: 27529125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria: an emerging target for therapeutics.
    Hersh SP
    Clin Pharmacol Ther; 2010 Jun; 87(6):630-2. PubMed ID: 20485316
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial medicine and therapeutics, Part II. Preface.
    Hamm-Alvarez S; Cadenas E
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1233. PubMed ID: 19835920
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular vehicles for mitochondrial chemical biology and drug delivery.
    Rin Jean S; Tulumello DV; Wisnovsky SP; Lei EK; Pereira MP; Kelley SO
    ACS Chem Biol; 2014 Feb; 9(2):323-33. PubMed ID: 24410267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-targeting particles.
    Wongrakpanich A; Geary SM; Joiner ML; Anderson ME; Salem AK
    Nanomedicine (Lond); 2014 Nov; 9(16):2531-43. PubMed ID: 25490424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.